[ad_1]
“Maintain a suitable temperature of 2 ~ 8 degrees during the distribution process of the relevant quantity”
“Three deaths after vaccination are considered independent of the vaccine”
The number of government-obtained influenza (flu) vaccines, which was suspended due to a report of suspected exposure to room temperature during transport, was confirmed to be 1,362, an increase of 489 in one day. 87% were concentrated, including 868 cases before the national vaccination project and 315 cases on the day of the suspension notification.
In the course of the investigation, it was revealed that 122 people were inoculated with government purchase amounts on the 25th, 3 days after business was suspended at a nursing hospital in Incheon. Of these, three people between the ages of 80 and 90 died, and expert advice suggests the disease was worse than vaccination.
According to a written response to the national influenza vaccination project distributed by the Korea Centers for Disease Control and Prevention (DMI) on the 30th, the number of government-purchased vaccines currently under investigation is 1,362 in 15 regions as of the 28th. This is an increase of 489 cases from a region of 873 cases in 14 regions that were confirmed on the 28th of the previous day.
By region, Jeonbuk was the largest with 326 cases, Gyeonggi 225 cases, Incheon 213 cases, Gyeongbuk 148 cases, Busan 109 cases, Chungnam 74 cases, Seoul 70 cases, Sejong 51 cases, Daegu 46 cases, Gwangju 40 cases, Jeonnam 31 cases, Daejeon There were 10 cases, 10 cases in Gyeongsangnam-do, 8 cases in Jeju, 1 case in Chungbuk, etc. The vaccination period was 868 cases 21 days before the start of the national influenza vaccination program, 63.7%, and the initial date of the project and the health authorities received a report of suspected exposure at room temperature. On the 22nd there were 315 cases that announced the suspension of the business, which represents 23.1%. 1,183 cases (86.8%) were concentrated, the problem is that there are medical institutions, etc., that have used the volume of government purchases even after the 22 announced that the business was suspended and this became known.
179 cases were confirmed, including 9 cases on 23 and 8 cases on 24, 128 cases on 25, 26 cases on 26 and 8 cases on 28.
Notably, 122 out of 233 hospitalized patients were confirmed to have received a government-supplied influenza vaccine at a nursing hospital in Incheon on the 25th during the local government investigation.
However, the vaccine supplied to the hospital is a separate quantity supplied by DL Pharm, a participating company in the Shinsung Pharmaceutical consortium, which is suspected of being exposed to room temperature. The disease agency reported that it was determined that the proper temperature was maintained throughout the process.
It was confirmed that three of the 122 people who received the vaccine died (86-year-old woman on the 26th, 88-year-old woman on the 28th and 91-year-old woman on the 29th), but it is believed that this is a case of death by worsening of the chronic disease (the underlying disease) rather than by vaccination. The disease agency explained.
An official from the Agency for Disease Control and Prevention said: “As a result of the expert advice meeting on the cases of adverse reactions reported up to the 30th and the corresponding cases of death, we reviewed that it was judged as a death due to the worsening of the underlying disease rather than the association of influenza vaccination. ” “No adverse reactions were found in the patients.” According to the death registry of the nursing hospital during the last two years, it was also confirmed that an average of 11 to 13 people die per month.
So far, there have been a total of 4 cases of adverse reactions reported after vaccination with the amount obtained by the government.
An official with the Agency for Disease Control and Prevention said: “The case that complained of pain at the first vaccination site improved symptoms.” “Additional cases include 1 fever, chills and muscle pain after vaccination and 1 hematoma at the vaccination site.” .
According to the Ministry of Food and Drug Safety, the vaccine that has been approved for shipment as a seasonal influenza vaccine is 190 batches (system unit number that means production under the same process conditions) 28.25 million dose (one dose) at 25 days. Among them, 51 batches of products purchased by the government were supplied through Shinsung Pharmaceutical, which is suspected of being exposed to room temperature.
Among the national influenza vaccination projects that began on the 22nd, the Agency for Disease Control and Prevention determined that there would be no related vaccines because a report of suspicion was received among persons 13 to 18 years of age and the use one day before vaccination.
However, in reality, it has been confirmed that some medical institutions have inoculated the vaccines provided by the government to the vaccines paid for before the national vaccination.
A total of 139 medical institutions have received vaccines from the government. Jeonbuk is the largest with 31 locations, Daegu 21 locations, Gyeonggi 20 locations, Busan, Chungnam, Gyeongbuk every 11 locations, Seoul 8 locations, Incheon, Gwangju, Daejeon 5 locations, Gyeongnam 4 locations, Jeju 3 locations, Jeonnam 2 locations, Sejong · 1 each in Chungbuk.
Regarding the medical institution that consigns the national vaccination project using the amount of vaccines purchased by the government, the Agency for Disease Control and Prevention said: “For the termination of the shipping contract with the medical institution and the measures Following up, the local government is reviewing and taking detailed action on the case. I’ll figure it out and let me know. “
[세종=뉴시스]Copyright by dongA.com All rights reserved.
